68382-447 : Bosentan 125 mg Oral Tablet, Coated


NDC: 68382-447
Labeler: Zydus Pharmaceuticals (Usa) Inc.
Product Type: Human Prescription Drug
Drug Name:  Bosentan
Dosage Form: Oral Tablet, Coated
Application #: ANDA207760
Rev. Date: 


Appearance:


Markings: 447
Shapes:  Oval
Colors:  Pink
Size (mm): 11
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 68382-447-01: 100 TABLET, COATED IN 1 BOTTLE (68382‑447‑01)
  • 68382-447-05: 500 TABLET, COATED IN 1 BOTTLE (68382‑447‑05)
  • 68382-447-14: 60 TABLET, COATED IN 1 BOTTLE (68382‑447‑14)
  • 68382-447-28: 180 TABLET, COATED IN 1 BOTTLE (68382‑447‑28)
  • 68382-447-77: 10 BLISTER PACK IN 1 CARTON (68382‑447‑77) > 10 TABLET, COATED IN 1 BLISTER PACK (68382‑447‑30)

Active Ingredients:

  • Bosentan

Dosage Strength:

  • 125 mg

Inactive Ingredients:

  • Ethylcelluloses
  • Ferric Oxide Red
  • Ferric Oxide Yellow
  • Glyceryl Dibehenate
  • Hypromelloses
  • Magnesium Stearate
  • Povidone
  • Sodium Starch Glycolate Type a Potato
  • Starch, Corn
  • Talc
  • Titanium Dioxide
  • Triacetin /

Pharmaceutical Classes:

  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Endothelin Receptor Antagonist [EPC]
  • Endothelin Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 68382-446 Bosentan 62.5 mg Oral Tablet, Coated by Zydus Pharmaceuticals (Usa) Inc.
  • 0054-0520 Bosentan 62.5 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0054-0521 Bosentan 125 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0591-2511 Bosentan 62.5 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 0591-2512 Bosentan 125 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 10148-125 Bosentan 125 mg Oral Tablet, Film Coated by Cotherix, Inc.
  • 10148-625 Bosentan 62.5 mg Oral Tablet, Film Coated by Cotherix, Inc.
  • 46708-383 Bosentan 62.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 46708-384 Bosentan 125 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Limited
  • 47335-038 Bosentan 62.5 mg Oral Tablet, Film Coated by Sun Pharmaceutical Industries, Inc.
  • 47335-039 Bosentan 125 mg Oral Tablet, Film Coated by Sun Pharmaceutical Industries, Inc.
  • 47781-270 Bosentan 62.5 mg Oral Tablet, Film Coated by Alvogen Inc.
  • 47781-271 Bosentan 125 mg Oral Tablet, Film Coated by Alvogen Inc.
  • 49884-058 Bosentan 62.5 mg Oral Tablet, Film Coated by Par Pharmaceutical, Inc.
  • 49884-059 Bosentan 125 mg Oral Tablet, Film Coated by Par Pharmaceutical, Inc.
  • 62332-383 Bosentan 62.5 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 62332-384 Bosentan 125 mg Oral Tablet, Film Coated by Alembic Pharmaceuticals Inc.
  • 65162-873 Bosentan 62.5 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC
  • 65162-874 Bosentan 125 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals LLC
  • 68180-386 Bosentan 125 mg Oral Tablet by Lupin Pharmaceuticals, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68382-447 QR Code

< Prev: 68382-446Next: 68382-452 >

Related Discussions:

Lupibose (Bosentan) Uses
What is Lupibose 62.5 mg (Bosentan) used for? ## Lupibose (Bosentan) is used to treat Pulmonary Artery Hypertension. Pos... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.